As the Structural Genomics Consortium enters its second decade, SciBX spoke with Aled Edwards about how the open-access business model has evolved globally and the organization's plans to engage clinician scientists and add a site in South America.
No takes yet. Share an insight, caveat, or question.
Amy Donner (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: